PB2173: THE EFFECT OF RUXOLITINIB THERAPY ON HEMOSTATIC PARAMETERS IN PATIENTS WITH PRIMARY MYELOFIBROSIS

Detalles Bibliográficos
Autores principales: Korsakova, Natalia, Silina, Natalia, Golovina, Olga, Efremova, Elizaveta, Voloshin, Sergey, Papayan, Ludmila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429185/
http://dx.doi.org/10.1097/01.HS9.0000975444.87143.d5
_version_ 1785090647499210752
author Korsakova, Natalia
Silina, Natalia
Golovina, Olga
Efremova, Elizaveta
Voloshin, Sergey
Papayan, Ludmila
author_facet Korsakova, Natalia
Silina, Natalia
Golovina, Olga
Efremova, Elizaveta
Voloshin, Sergey
Papayan, Ludmila
author_sort Korsakova, Natalia
collection PubMed
description
format Online
Article
Text
id pubmed-10429185
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104291852023-08-17 PB2173: THE EFFECT OF RUXOLITINIB THERAPY ON HEMOSTATIC PARAMETERS IN PATIENTS WITH PRIMARY MYELOFIBROSIS Korsakova, Natalia Silina, Natalia Golovina, Olga Efremova, Elizaveta Voloshin, Sergey Papayan, Ludmila Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429185/ http://dx.doi.org/10.1097/01.HS9.0000975444.87143.d5 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Korsakova, Natalia
Silina, Natalia
Golovina, Olga
Efremova, Elizaveta
Voloshin, Sergey
Papayan, Ludmila
PB2173: THE EFFECT OF RUXOLITINIB THERAPY ON HEMOSTATIC PARAMETERS IN PATIENTS WITH PRIMARY MYELOFIBROSIS
title PB2173: THE EFFECT OF RUXOLITINIB THERAPY ON HEMOSTATIC PARAMETERS IN PATIENTS WITH PRIMARY MYELOFIBROSIS
title_full PB2173: THE EFFECT OF RUXOLITINIB THERAPY ON HEMOSTATIC PARAMETERS IN PATIENTS WITH PRIMARY MYELOFIBROSIS
title_fullStr PB2173: THE EFFECT OF RUXOLITINIB THERAPY ON HEMOSTATIC PARAMETERS IN PATIENTS WITH PRIMARY MYELOFIBROSIS
title_full_unstemmed PB2173: THE EFFECT OF RUXOLITINIB THERAPY ON HEMOSTATIC PARAMETERS IN PATIENTS WITH PRIMARY MYELOFIBROSIS
title_short PB2173: THE EFFECT OF RUXOLITINIB THERAPY ON HEMOSTATIC PARAMETERS IN PATIENTS WITH PRIMARY MYELOFIBROSIS
title_sort pb2173: the effect of ruxolitinib therapy on hemostatic parameters in patients with primary myelofibrosis
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429185/
http://dx.doi.org/10.1097/01.HS9.0000975444.87143.d5
work_keys_str_mv AT korsakovanatalia pb2173theeffectofruxolitinibtherapyonhemostaticparametersinpatientswithprimarymyelofibrosis
AT silinanatalia pb2173theeffectofruxolitinibtherapyonhemostaticparametersinpatientswithprimarymyelofibrosis
AT golovinaolga pb2173theeffectofruxolitinibtherapyonhemostaticparametersinpatientswithprimarymyelofibrosis
AT efremovaelizaveta pb2173theeffectofruxolitinibtherapyonhemostaticparametersinpatientswithprimarymyelofibrosis
AT voloshinsergey pb2173theeffectofruxolitinibtherapyonhemostaticparametersinpatientswithprimarymyelofibrosis
AT papayanludmila pb2173theeffectofruxolitinibtherapyonhemostaticparametersinpatientswithprimarymyelofibrosis

Ejemplares similares